Page 1

IMCD Press release IMCD reports 28 % EBITA growth in the first three months of 2021 Rotterdam , The Netherlands ( 29 April 2021 ) - IMCD N.V. ( " IMCD " or " Company " ) , a leading distributor of speciality chemicals and ingredients , today announces its first three months 2021 results HIGHLIGHTS • • . • • Gross profit growth of 12 % to EUR 197.6 million ( + 17 % on a constant currency basis ) Operating EBITA increase of 28 % to EUR 90.6 million ( + 34 % on a constant currency basis ) Net result before amortisation and non - recurring items increase of 27 % to EUR 63.8 million ( + 32 % on a constant currency basis ) Cash earnings per share increased by 18 % to EUR 1.11 ( first three months of 2020 : EUR 0.94 ) Further strengthening of the pharma , food and personal care activities in EMEA by the completion of three acquisitions ( Ejder Kimya , Siyeza Fine Chem Propriety Limited and the pharmaceutical business of Peak International Products B.V. ) Piet van der Slikke , CEO : " I am pleased to report that IMCD had a strong start of the year . Our team performed excellently despite challenges from Covid , product shortages and disturbances in supply chains . We experienced strong demand in particular in the industrial sector . Acquisitions completed last year performed in accordance with expectations . This resulted in an operating EBITA growth of 28 % ( + 34 % on a constant currency base ) and in favourable development of other KPI's as well . Free cash flow grew to EUR 63.6 million ( + 91 % ) and cash earnings per share was up 18 % . All regions contributed to these results . We continue to execute our strategy diligently by working hard on further digitalising our business , providing sustainable product solutions to our customers and strengthening our presence in various markets . With this promising start , I am optimistic that the quality of our staff and the strength of our business model enables IMCD to further grow its business this year . " KEY FIGURES FX . ADJ . EUR MILLION Revenue JAN . 1 - MARCH 31 2021 JAN . 1 - MARCH 31 2020 CHANGE CHANGE % CHANGE 809.9 748.8 61.1 8 % 13 % Gross profit 197.6 176.4 21.2 12 % 17 % Gross profit in % of revenue 24.4 % 23.6 % 0.8 % Operating EBITA¹ 90.6 70.9 19.7 28 % 34 % Operating EBITA in % of revenue 11.2 % 9.5 % 1.7 % Conversion margin² 45.9 % 40.2 % 5.7 % Net result before amortisation / non - recurring items 63.8 50.2 13.5 27 % 32 % Free cash flow³ 63.6 33.3 30.3 91 % Cash conversion margin 69.6 % 46.2 % 23.4 % Earnings per share ( EUR ) 0.82 0.71 0.11 16 % 23 % Cash earnings per share ( EUR ) 5 1.11 0.94 0.17 18 % 22 % Number of full time employees end of period 3,360 3,064 296 10 % 1 Result from operating activities before amortisation of intangibles and non - recurring items 2 Operating EBITA in percentage of gross profit 3 Operating EBITDA excluding non - cash share - based payment expenses , less lease payments , plus / less changes in working capital , less capital expenditures 4 Free cash flow in percentage of adjusted operating EBITDA ( operating EBITDA plus non - cash share based payment costs , minus lease premiums ) 5 Result for the year before amortisation ( net of tax ) divided by the weighted average number of outstanding shares Value through expertise